FDA Approves GSK’s 5-in-1 Meningococcal Vaccine
On Feb. 14, 2025, British pharmaceutical and biotechnology company GSK plc announced that the U.S. Food and Drug Administration (FDA) approved its 5-in-1 meningococcal vaccine PENMENVY for licensure and use in individuals aged 10 through 25 years. The vaccine targets five major serogroups of the bacterium Neisseria meningitidis (A, B, C, W, and Y), which […]
Measles Outbreak in Texas
There has been a lot of media attention given lately to the measles outbreak in Texas. The outbreak now accounts for 90 cases—77 of them involving children under the age of 18. It has been reported that “most of those infected” either have not be vaccinated for measles or have an “unknown vaccination status,” while […]
FDA Requires RSV Vaccine Labels to Include Guillain-Barré Syndrome Risk
On Jan. 7, 2025, the U.S. Food and Drug Administration (FDA) mandated and approved changes to the safety labeling for the Prescribing Information of two Respiratory Syncytial Virus (RSV) vaccines: Abrysvo (manufactured by Pfizer)1 and Arexvy (manufactured by GlaxoSmithKline Biologicals).2 This label change update is being required to inform both the public and health care […]
Are Influenza Vaccine Failures One Reason for Declining Flu Shot Uptake?
The rates of adults and children in the United States receiving influenza vaccinations have been steadily declining in recent years, according to the U.S. Centers for Disease Control and Prevention (CDC). During the 2019-2020 “flu season,” 63.7 percent of American children between six months to 17 years of age received flu shots, compared to 55.4 […]
Big Pharma’s Rap Sheet
It was one of those conversations you never forget. We were discussing—of all things—the Covid injections, and I was questioning the early ‘safe and effective’ claims put forward by the pharmaceutical industry. I felt suspicious of how quickly we had arrived at that point of seeming consensus despite a lack of long-term safety data. I […]
CDC Narrows RSV Vaccine Guidelines Due to Safety Concerns
The U.S. Centers for Disease Control and Prevention (CDC) has recently narrowed its original recommendations for the respiratory syncytial virus (RSV) vaccine, citing concerns over the risk of a side effect that can lead to paralysis or death. The recommendations originally stated adults over the age of 60 should receive the vaccine, but updates in […]